Speaker Interview With Frank Borriello For 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
Philadelphia, USA July 31, 2019 – MarketsandMarkets recently interviewed Frank Borriello, CEO, Alloplex Biotherapeutics, regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City.
Q. What are the recent advances in the immune-oncology and current challenges that need immediate attention?
A. While there have been many advances in the field of cellular therapy in oncology, the common element limiting their adoption will be reproducibility of manufacturing, whether autologous or allogeneic, as well as generalizability across multiple tumor types, whether liquid or solid tumors.
Q. What are the new opportunities emerging in your field of work?
A. Exploring the combinatorial space of immunostimulatory signals to elicit therapeutic immune responses in the context of cancer and autoimmunity.
Q. What are the key take away points from your presentation topic which will help in building the knowledge base of attendees?
- Cellular therapies are a versatile platform with multiple simultaneous MOAs possible; CAR-T is but the simplest case of coupling mAb specificity to effector T cell function.
- Allogeneic tumor cell lines engineered to express immunomodulatory proteins make it possible to stimulate readily available PBMC through naturally occurring receptors, leading to a heterogeneous effector population with broad anti-tumor activity.
- Simplicity and reproducibility of manufacturing is essential to the effective and affordable commercialization of both autologous and allogeneic cellular therapies
Q. Hope you had a chance to go through the agenda, what are your views on it and how helpful it is to the targeted audience?
A. The only issue I see is that many people would like talks in both tracks. There are many ways to group talks and this is as good as any. People will always have a conflict.
Frank Borriello will present on “ex vivo PBMC Activation of Antitumor Activity Offers Accelerated Path to Clinical Application”
The latest conference agenda and complete speaker line-up is available to download on the conference page, where you can also register – https://bit.ly/2LNkgpQ
For more inquiries contact Amit Shelke, Marketing Manager on [email protected]
